Posts about
Life At Veristat
Veristat Announces New Investment Partner—WindRose Health Investors
Recapitalization Will Accelerate Strategic Growth to Help Sponsors Save and Improve the Lives of Patients
Veristat Supported Marketing Applications for 10% of all FDA Novel Drug Approvals in 2020
Strengthening its Track Record of Successful Client Regulatory Approval Outcomes
SOUTHBOROUGH, MA – January 14, 2021 – Veristat, a...
Veristat Launches Business Operations in Spain and Names Dr. Montserrat Barceló to Vice...
Leading the Organic and Acquisition Growth of Veristat Operations Throughout Europe
Veristat Expands Operations into Taiwan
Veristat Expands Operations into Taiwan to Support Growing Client Demand for Clinical Trial, Biostatistics and Programming Excellence in the...
Veristat Strengthens Clinical Operations Capabilities - Acquires Topstone Research
Expanding Its Clinical Operations and Biometrics Teams Dedicated to Emerging, Small and Mid-Sized Biopharma
Veristat is Recognized on the Inc. 5000 List of America’s Fastest-Growing Private Companies...
Veristat’s Continued Innovation of Its Clinical Development Strategies and Services Allow the Company to Execute High Quality Trials That...
Veristat Recognized for a Third Consecutive Year on the Inc. 5000 List of America’s...
Veristat’s Growth Positively Impacts Our Ability to Help Clients Achieve Regulatory Approval of their Life-Changing and Life-Saving Therapies
Veristat Acknowledged on Boston Business Journal’s “Fast 50” List for a Second Consecutive...
Ranked as one of the Top 50 Fastest Growing Private Companies in Massachusetts